Epithalon (Epitalon) Primary uses: Longevity Telomere lengthening Sleep regulation (melatonin) Anti-aging Typical dosing: 10mg per cycle 1mg daily for 10 days Cycles: Every 3-6 months Administration: Subcutaneous injection Special notes: Strong evidence for telomere lengthening Used in anti-aging protocols Well-tolerated Improves sleep regulation (pineal gland function) Thymosin Alpha-1 Primary uses: Immune system optimization Anti-viral effects Longevity Chronic illness support Typical dosing: 0.5-1mg, 2-3 times per week Duration: Ongoing or cycles Administration: Subcutaneous injection Special notes: Powerful immune modulator FDA-approved for hepatitis (Zadaxin) Well-studied safety profile Used in longevity protocols Selank Primary uses: Anxiety reduction Cognitive enhancement Immune modulation Neuroprotection Typical dosing: 250-500mcg daily Injectable or intranasal Duration: 2-4 weeks, then break Administration: Subcutaneous injection or intranasal spray Special notes: Developed in Russia Anxiolytic without sedation Improves focus and mental clarity No dependence or withdrawal Semax Primary uses: Cognitive enhancement Focus and concentration Neuroprotection Stroke recovery Typical dosing: 300-600mcg daily Injectable or intranasal Duration: 2-4 weeks, then break Administration: Subcutaneous injection or intranasal spray Special notes: Powerful nootropic Increases BDNF (brain-derived neurotrophic factor) Improves learning and memory Developed in Russia Sexual health peptides These enhance libido, arousal, and sexual function
BPC-157 20mg Strength: 20 mg CAS: 137525-51-0 Chemical Formula: CHNO Molecular weight: 1419.5 g/mol Peptide Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Synonyms: BPC157, Bepecin Storage: Store 28 C (20 C long-term)
This makes it challenging to counteract oxidative stress once it occurs.Neuroinflammatory Processes: Neuroinflammation, often seen in neurodegenerative diseases, can exacerbate oxidative stress
Our team is dedicated to ensuring you achieve the best possible outcomes and continue to feel the benefits long after the treatment.
A pilot study on intraarticular knee pain found that 7 of 12 patients reported improvement lasting six or more months
